Sort   by:  
 Page size 
UnknownPML hyposumoylation is responsible for the resistance of pancreatic cancer.
Not available
S-EPMC6902661 | biostudies-literature
UnknownMYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway.
Not available
S-EPMC11806050 | biostudies-literature
UnknownImplementing biological markers as a tool to guide clinical care of patients with pancreatic cancer.
Not available
S-EPMC7704461 | biostudies-literature
TranscriptomicsTranscription profiling of wheat transcriptional reprogramming induced by Ptr ToxA in wheat
Transcriptional time course analysis of Wheat leaves in response to exposure to the fungal toxin ToxA from Pyrenophora tritici-repentis.
ORGANISM(S): Triticum aestivum 
2010-05-27 | E-MEXP-2203 | biostudies-arrayexpress
UnknownLimitation and challenges in using pancreatic cancer-derived organoids as a preclinical tool.
Not available
S-EPMC9558692 | biostudies-literature
ProteomicsNUPR1 inhibits hyperPARylation-associated cell death
Nuclear Protein 1 (NUPR1) is a nuclear intrinsically disordered protein of 82 amino acids that plays an important role in stress response and in cancer development. The project was aimed at identifying binding partners of NUPR1 in MiaPaCa-2 cells, in control and after stress condition: glucose starv...
ORGANISM(S): Homo sapiens (Human) 
2022-07-29 | PXD035236 | Pride
Lc-msms Pancreatic cancer Nupr1 Interactome 
UnknownOligomerization and phosphorylation dependent regulation of ArgBP2 adaptive capabilities and associated functions.
Not available
S-EPMC3903627 | biostudies-literature
UnknownOxidative stress-induced p53 activity is enhanced by a redox-sensitive TP53INP1 SUMOylation.
Not available
S-EPMC4207477 | biostudies-literature
UnknownSingle and combinatorial chromatin coupling events underlies the function of transcript factor Kruppel-like factor 11 in the regulation of gene networks.
Not available
S-EPMC4049485 | biostudies-literature
UnknownDevelopment of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer.
Not available
S-EPMC11422012 | biostudies-literature
Sort   by:  
 Page size